$GEVO

Gevo stock price target maintained at $14 by H.C. Wainwright

H.C. Wainwright maintained a $14 price target on Gevo (NASDAQ:GEVO), representing significant upside from its current $1.35 share price. The company reported a 121% revenue growth over the last year but has seen a 32.5% YTD stock decline. Gevo recently sold CO₂-removal credits and expects increased production capacity by year-end 2026. The company also reported better-than-expected Q2 2026 results, with narrower losses and raised its full-year EBITDA outlook to over $60 million.

Original reporting
Published Oct 9, 2026, 11:38 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 11:49 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$GEVO
Neutral
medium confidence
Mentioned
$GEVO
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$GEVONeutralLow
01

Why it matters

Analyst upgrade may provide short‑term price support, but the company's small market cap and cash‑burn risk limit upside potential.

02

Market read

The news is a post‑earnings analyst upgrade for a micro‑cap renewable‑fuel company, offering limited trading relevance.

03

What to watch

Future credit‑generation capacity and upcoming CO₂‑removal credit sales could materially improve cash flow if realized.

Relevance 4/10Novelty 2/10Timing: post‑earnings recap

Background

Gevo (NASDAQ:GEVO) reported Q2 2026 earnings that beat expectations, narrowed loss, raised revenue and EBITDA guidance, and secured carbon‑credit sales. H.C. Wainwright raised its price target to $14.

Company-level read

Ticker impact

$GEVONeutralMedium confidence
Context

Analyst H.C. Wainwright reiterated a Buy rating and raised the price target to $14 after Gevo's Q2 2026 earnings beat and upgraded guidance.

Expected impact

potential modest upside as market prices in higher target, tempered by cash‑burn concerns

Evidence & confidence

The price target increase reflects optimism, yet the company remains small with limited liquidity; price move likely limited.

Market effects

Highlights growing interest in renewable fuels and carbon‑credit markets, but limited broader sector impact.

Primarily U.S. small‑cap investors; no significant regional effect.

Minimal global relevance beyond niche renewable‑fuel niche.

Counterpoint

Despite the upgraded target, the company's cash burn and modest scale may keep the stock under pressure.

Key entities

  • Gevo, Inc.

    Renewable fuels producer focusing on isobutanol and carbon‑credit monetization.

  • H.C. Wainwright

    Equity research firm that reiterated a Buy rating and raised the price target.

Related articles

$GEVOMed

Gevo Announces Sell Out of Substantially All its 2026 Section 45Z Tax Credits

Gevo, Inc. (NASDAQ: GEVO) announced the sale of $70 million in Section 45Z tax credits, with $30 million received by September 30. The credits were sold to a public company and Quill Financial, Inc. Gevo expects additional credits worth $7-10 million in 2027. The company plans to reinvest proceeds into low-cost clean fuel production, aiming to enhance shareholder value.

$MURMed

Unpacking Q2 Earnings: Murphy Oil (NYSE:MUR) In The Context Of Other Mixed or Offshore Upstream E&P Stocks

Murphy Oil (NYSE:MUR) reported Q2 revenue of $928.3M, up 33.5% YoY, beating estimates. The stock rose 7% post-earnings. The article also covers other mixed or offshore upstream E&P stocks, including Granite Ridge Resources (NYSE:GRNT), Peabody Energy (NYSE:BTU), Seadrill (NYSE:SDRL), and Gevo (NASDAQ:GEVO), highlighting their Q2 performances and stock movements.

$GEVOMedAI 8/10

Gevo (GEVO) Q2 2026 Earnings Call Transcript

Gevo (GEVO) reported Q2 2026 revenue of $47 million, up 7% year over year, and non-GAAP adjusted EBITDA of $11 million. Full-year 2026 adjusted EBITDA guidance is now above $60 million. The company targets $70 million of 45Z tax credit monetization in 2026 and recorded a $176 million noncash impairment tied to exiting its ATJ-60 project.